Nasopharyngeal Carcinoma — Trials

Nasopharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 246
Recruiting: 131
Ph III recruiting: 54
Growth YoY: +5.4%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 22.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05904080	Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer	suspended	Phase 2	50	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials
NCT02022293	Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis	suspended	Phase 2	324	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	1	Dec 4, 2017